Treatments & Interventions
Loxapine hydrochloride
substance
Prochlorperazine edisylate
substance
Cyproheptadine hydrochloride
substance
Thioridazine hydrochloride
substance
Prochlorperazine maleate
substance
Perazine
substance
Tiotixene hydrochloride
substance
Loxapine succinate
substance
Acetophenazine
substance
Trifluoperazine hydrochloride
substance
Molindone hydrochloride
substance
Methotrimeprazine hydrochloride
substance
Fluphenazine hydrochloride
substance
Acetophenazine maleate
substance
Piperacetazine
substance
Mesoridazine besylate
substance
Promazine hydrochloride
substance
Quetiapine fumarate
substance
Selegiline hydrochloride
substance
Fluophenazine enanthate
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 191526005
- UMLS CUI
- C0036341
- Fully Specified Name
- Schizophrenic disorders (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 6
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.